G-Force PD: a global initiative in coordinating stem cell-based dopamine treatments for Parkinson’s disease

02 Oct

G-Force PD: a global initiative in coordinating stem cell-based dopamine treatments for Parkinson’s disease – npj Parkinson’s Disease

Translating new cell-based therapies to the clinic for patients with neurodegenerative disorders is complex. It involves pre-clinical testing of the cellular product and discussions with several regulatory agencies, as well as ethical debates.

Written by Stefan

June 2013 – Present: Program Manager, Memorial Sloan-Kettering Cancer Center July 2009 – June 2012: iPierian, Senior Scientist & Project Team Leader January 2007 – June 2009: Postdoctoral fellow, University Health Network October 2003 – December 2006: Postdoctoral fellow, Mount Sinai School of Medicine